Skip to main content

Find Clinical Trials

Home
Conditions
BRAF V600E Mutation

Clinical trial condition

BRAF V600E Mutation

Explore clinical trials studying BRAF V600E Mutation. Study availability and eligibility vary by location and protocol.

4 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

BRAF V600E Mutation trial results

Recruiting

Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer

NCT07617610

Conditions: BRAF V600E Mutation, Colonic Diseases, Colorectal Neoplasms, +10 more
Locations: Kantonsspital Aarau Aarau, Switzerland

Kantonsspital Baden Baden, Switzerland

St. Claraspital Basel, Switzerland

Universitaetsspital Basel Basel, Switzerland

View all 13 locations

View Trial Details

Recruiting

A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-altered Glioma

NCT06610682

Conditions: BRAF V600E Mutation, Disease Attributes, Pathologic Processes, +2 more
Locations: Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Not Yet Recruiting

Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib

NCT05988697

Conditions: Advanced Cancer, BRAF V600E Mutation, Bronchial Neoplasms, +12 more
Locations: Not specified

View Trial Details

Completed

Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease

NCT02281760

Conditions: BRAF V600E Mutation, Hemic and Lymphatic Diseases, Histiocytosis, +2 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details